Citation:HALT-C Trial Group, Lok AS, Seeff LB, Morgan TR, di Bisceglie AM, Sterling RK, et al 2009

From National Cancer Control Policy

HALT-C Trial Group, Lok AS, Seeff LB, Morgan TR, di Bisceglie AM, Sterling RK, et al. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology 2009 Jan;136(1):138-48 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/18848939.


Critical appraisals


Cited by

  1. Liver cancer/Causes
  2. Liver cancer/Screening